41 results
Page 2 of 3
8-K
EX-99.1
ndy9gfodx0v u0pmxt
12 Aug 21
Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights
4:18pm
424B4
ogg3u0an
18 Jun 21
Prospectus supplement with pricing info
12:00am
S-1/A
yc0ghu61 bzf
9 Jun 21
IPO registration (amended)
7:12am
S-1/A
EX-10.15
wd8m6 pp59pv
9 Jun 21
IPO registration (amended)
7:12am
S-1
EX-10.21
4jq3l7zt7lzhjv9256x
25 May 21
IPO registration
5:28pm
S-1
EX-10.17
sqead31rxcobkoj0
25 May 21
IPO registration
5:28pm
S-1
EX-10.22
schueyi6
25 May 21
IPO registration
5:28pm
S-1
EX-10.14
f9ytc4a de4wn7hc
25 May 21
IPO registration
5:28pm
S-1
EX-10.23
4kgg0 zxk2kzt2j81d
25 May 21
IPO registration
5:28pm
S-1
EX-10.18
cunsgbrwp1g7ag o46p
25 May 21
IPO registration
5:28pm
S-1
eawwvda qfy44mpoc
25 May 21
IPO registration
5:28pm
S-1
EX-10.15
nzd50mt
25 May 21
IPO registration
5:28pm
DRS/A
tdmf0ln43am8cylwxv
12 May 21
Draft registration statement (amended)
12:00am
DRS
EX-10.18
tnv86ggt5cyuwt
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.22
3ao nyvwg
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.21
wcj6w7isx
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.23
nuelkai cc
12 Apr 21
Draft registration statement
12:00am
DRS
bmwqdd4zfp315
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.14
wcs3jwj2weyjf7z
12 Apr 21
Draft registration statement
12:00am
DRS
EX-10.15
356ju31y7pz 5kn
12 Apr 21
Draft registration statement
12:00am